Table I.
Demographic information of patients with ESCC included in the study (n=14). The TNM stage and pathology stage of ESCC were defined following the American Joint Committee on Cancer cancer staging protocol.
Patient ID | 12 | 13 | 14 | 16 | 19 | 20 | 21 | 23 | 29 | 30 | 32 | 33 | 5 | 6 |
Age, years | 62 | 73 | 63 | 59 | 69 | 60 | 70 | 71 | 65 | 64 | 62 | 45 | 62 | 53 |
Sex | F | F | F | F | F | M | F | M | F | F | M | M | M | M |
TNM stage | T3N0M0 | T3N0M0 | T3N1M0 | T3N2M0 | T2N0M0 | T3N0M0 | T1bN0M0 | T1aN0M0 | T3N2M0 | T1bN1M0 | T2N1M0 | T1bN1M0 | T3N2M0 | T3N0M0 |
Pathological stage | IIB | IIB | IIIA | IIIB | IIA | IIB | IA | IB | IIIB | IIB | IIA | IIB | IIIB | IIB |
TNM, tumor-node-metastasis; ESCC, esophageal squamous cell cancer; M, male; F, female.